Association of single nucleotide polymorphisms in CYP1B1 and COMT genes with breast cancer susceptibility in Indian women

Disease Markers

Volumn 27, Issue 5, 2009, Pages 203-210

  Yadav, Sharawan ^a   Singhal, Naveen Kumar ^a   Singh, Virendra ^a   Rastogi, Neeraj ^b   Srivastava, Pramod Kumar ^c   Singh, Mahendra Pratap ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c BANARAS HINDU UNIVERSITY   (India)

Author keywords

Breast cancer; COMT; CYP1B1; Genetic polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1B1; LEUCINE; METHIONINE; VALINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; INDIA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; WILD TYPE;

EID: 77249115185     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2009-0663     Document Type: Article

References (39)

1. S.E. Hankinson, W.C.Willett, J.E. Manson G.A. Colditz, D.J. Hunter, D. Spiegelman, R.L. Barbieri and F.E. Speizer, Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women, J Natl Cancer Inst 90 (1999), 1292-1299.
2. E.A. Mady, E.E. Ramadan and A.A. Ossman, Sex steroid hormones in serum and tissue of benign and malignant breast tumor patients, Dis Markers 16 (2000), 151-157.
3. L.M. Morimoto, E. White, Z. Chen, R.T. Chlebowski, J. Hays, L. Kuller, A.M. Lopez, J. Manson, K.L. Margolis, P.C. Muti, M.L. Stefanick and A. McTiernan, Obesity, body size, and risk of postmenopausal breast cancer: the women's health initiative (United States), Cancer Causes Control 13 (2002), 741-751.
4. S.S. Coughlin and M. Piper, Genetic polymorphisms and risk of breast cancer, Cancer Epidemiol Biomarkers Prev 8 (1999), 1023-1032.
5. A.M. Dunning, C.S. Healey, P.D. Pharoah, M.D. Teare, B.A. Ponder and D.F. Easton. A systematic review of genetic polymorphisms and breast cancer risk, Cancer Epidemiol Biomark Prev 8 (1999), 843-854.
6. V.N. Kristensen and A.L. Borresen-Dale, Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism, Mutat Res 462 (2000), 323-333.
7. W.Wen, Q. Cai, X.O. Shu, C. Jia-Rong, F. Parl, L. Pierce, Y.T. Gao and W. Zheng, Cytochrome P450 1B1 and catechol-Omethyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the Shanghai breast cancer study and a meta-analysis, Cancer Epidemiol Biomarkers Prev 14 (2005), 329-335.
8. V. Paracchini, S. Raimondi, I.T. Gram, D. Kang, N.A. Kocabas, V.N. Kristensen, D. Li, F.F. Parl, T. Rylander-Rudqvist, P. Soucek, W. Zheng, S. Wedren and E. Taioli. Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review, Am J Epidemiol 165 (2007), 115-125.
9. T.R. Sutter, Y.M. Tang, C.L. Hayes, Y.Y. Wo, E.W. Jabs, X. Li, H. Yin, C.W. Cody and W.F. Greenlee, Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2, J Biol Chem 269 (1994), 13092-13099.
10. Y.M. Tang, Y.Y. Wo, J. Stewart, A.L. Hawkins, C.A. Griffin, T.R. Sutter and W.F. Greenlee, Isolation and characterization of the human cytochrome P450 CYP1B1 gene, J Biol Chem 271 (1996), 28324-28330.
11. M.H. Grossman, B.S. Emanueal and M.L. Budarf, Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2, Genomics 12 (1992), 822-825.
12. K. Lundstrom, M. Salminen, A. Jalanko, K. Savolainen and I. Ulmanen, Cloning, expression and structure of catechol-Omethyltransferase, Biochim Biophys Acta 1251 (1995), 1-10.
13. J. Tenhunen, M. Salminen, A. Jalanko, S. Ukkonen and I. Ulmanen, Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme, DNA Cell Biol 12 (1993), 253-263.
14. J. Tenhunen, M. Salminen, K. Lundström, T. Kiviluoto, R. Savolainen and I. Ulmanen, Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters, Eur J Biochem 223 (1994), 1049-1059.
15. C.L. Hayes, D C Spink, B C Spink, J Q Cao, N JWalker and T R Sutter, 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1, Proc Natl Acad Sci USA 93 (1996), 9776-9781.
16. J.D. Yager and J.G. Liehr, Molecular mechanisms of estrogen carcinogenesis, Annu Rev Pharmacol Toxicol 36 (1996), 203-232.
17. B.T. Zhu and A.H. Conney, Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis, Cancer Res 58 (1998), 2269-2277.
18. B.T. Zhu, Medical hypothesis: hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancer, Int J Oncol 22 (2003), 499-508.
19. J.J. Li and S.A. Li, Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism, Fed Proc 46 (1987), 1858-1863.
20. T. Shimada, J. Watanabe, K. Kawajiri, T.R. Sutter, F.P. Guengerich, E.M.J. Gillam and K. Inoue, Catalytic properties of polymorphic human cytochrome P450 1B1 variants, Carcinogenesis 20 (1999), 1607-1613. (Pubitemid 29385452)
21. E. Aklillu, M. Oscarson, M. Hidestrand, B. Leidvik, C. Otter and M. Ingelman-Sundberg, Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population, Mol Pharmacol 61 (2002), 586-594.
22. S. Dawling, N. Roodi, R.L. Mernaugh, X. Wang and F.F. Parl, Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms, Cancer Res 61 (2001), 6716-6722.
23. T. Rastogi, A. Hildesheim and R. Sinha, Opportunities for cancer epidemiology in developing countries, Nat Rev Cancer 4 (2004), 909-917.
24. V. Singh, N. Rastogi, N. Mathur, K. Singh and M.P. Singh, Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women, Ann Epidemiol 18 (2008), 48-57.
25. V. Singh, N. Rastogi, A. Sinha, A. Kumar, N. Mathur and M.P. Singh, A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women, Breast Cancer Res Treat 101 (2007), 73-81.
26. S.A. Miller, D.D. Dykes and H.F. Polesky, A simple salting out procedure for extracting DNAfrom human nucleated cells, Nucleic Acids Res 16 (1988), 1215.
27. G. Suman, K. Jamil, K. Suseela and M.C. Vamsy, Novel mutations of CYP3A4 in fine needle aspiration cytology samples of breast cancer patients and its clinical correlations, Cancer Biomark 5 (2009), 33-40.
28. J.L. Fleiss, Statistical Methods for Rates and Proportion, 2nd ed., Wiley-Liss Inc, New York, 1981, pp. 38-45.
29. A.M. Dunning, M. Dowsett, C.S. Healey, L. Tee, R.N. Luben, E. Folkerd, K.L. Novik, L. Kelemen, S. Ogata, P.D.P. Pharoah, D.F. Easton, N. E. Day and B.A. J. Ponder, Polymorphisms associated with circulating sex hormone levels in postmenopausal women, J Natl Cancer Inst 96 (2004), 936-945.
30. T. Rylander-Rudqvist, S. Wedren, F. Granath, K. Humphreys, S. Ahlberg, E. Weiderpass, M. Oscarson, M. Ingelman- Sundberg and I. Persson, Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk, Carcinogenesis 24 (2003), 1533-1539.
31. K.M. Lee, J. Abel, Y. Ko, V. Harth, W.Y. Park, J.S. Seo, K.Y.Yoo, J.Y. Choi, A. Shin, S.H. Ahn, D.Y. Noh, A. Hirvonen and D. Kang, Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women, Br J Cancer 88 (2003), 675-678.
32. N.A. Kocabas, S. Sardas, S. Cholerton, A.K. Daly and A.E. Karakaya, Cytochrome P450 CYP1B1 and catechol-Omethyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population, Arch Toxicol 76 (2002), 643-649.
33. I.H. Hanna, S. Dawling, N. Roodi, F.P. Guengerich and F.F. Parl, Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity, Cancer Res 60 (2000), 3440-3444.
34. H.C. Guldberg and C.A. Marsden, Catechol-O-methyl transferase: pharmacological aspects and physiological role, Pharmacol Rev 7 (1975), 419-424.
35. L.R. Bailey, N. Roodi, W.D. Dupont and F.F. Parl, Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer, Cancer Res 58 (1998), 5038-5041.
36. W. Zheng, D.W. Xie, F. Jin, J.R. Cheng, Q. Dai, W.Q. Wen, X.O. Shu and Y.T. Gao, Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer, Cancer Epidemiol Biomarkers Prev 9 (2000), 147-150.
37. A.H. Wu, C.C. Tseng, D. Vandenberg and M.C. Yu, Tea intake, COMT genotype, and breast cancer in Asian-American women, Cancer Res 63 (2003), 7526-7529.
38. J.A. Lavigne, K.J. Helzlsouer, H.Y. Huang, P.T. Strickland, D.A. Bell, O. Selmin, M.A. Watson, S. Hoffman, G.W. Comstock and J.D.Yager, An association between the allele coding for a low activity variant of catechol-O- methyltransferase and the risk for breast cancer, Cancer Res 57 (1997), 5493-5497.
39. K. Mitrunen, N. Jourenkova, V. Kataja, M. Eskelinen, V.M. Kosma, S. Benhamou, D. Kang, H. Vainio, M. Uusitupa and A. Hirvonen, Polymorphic catechol-O-methyltransferase gene and breast cancer risk, Cancer Epidemiol Biomarkers Prev 10 (2001), 635-640. (Pubitemid 32703197)